Role of a mixed probiotic product, VSL#3, in the prevention and treatment of colorectal cancer-Reference-Cited by-同舟云学术

Role of a mixed probiotic product, VSL#3, in the prevention and treatment of colorectal cancer

Published:2022-09 Issue: Volume:930 Page:175152
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Wei Lijuan,Duan Liwei,Zhao Hongyu,Tai Jinghua

Funder

Jilin Department of Health

Publisher

Elsevier BV

Subject

Pharmacology

Reference160 articles.

1. Cruciferous vegetables and their bioactive metabolites: from prevention to novel therapies of colorectal cancer;Agagunduz;Evid. Based Complement. Alternat. Med.,2022

2. Anticancer potential of furanocoumarins: mechanistic and therapeutic aspects;Ahmed;Int. J. Mol. Sci.,2020

3. Is emodin with anticancer effects completely innocent? Two sides of the coin;Akkol;Cancers,2021

4. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer;Appleyard;Am. J. Physiol. Gastrointest. Liver Physiol.,2011

5. Global patterns and trends in colorectal cancer incidence and mortality;Arnold;Gut,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probiotics intervention for type 2 diabetes mellitus therapy: a review from proposed mechanisms to future prospects;Critical Reviews in Food Science and Nutrition;2024-08-08

2. Clarifying correct attributions in scientific literature: The case of the De Simone Formulation and the VSL#3®;Clinical Nutrition;2024-07

3. Recombinant probiotic Lactococcus lactis delivering P62 mitigates moderate colitis in mice;Frontiers in Microbiology;2024-04-04